Line K. Vibholm - Concepedia

Author

Line K. Vibholm

Also Known As

L Vibholm, Line Khalidan Vibholm, Line K Vibholm, Line K. Vibholm, Line Khalidan Vibholm, Line Vibholm, Vibholm, Line Khalidan

Publications

874

Citations

H-Index

Concepts

All Affiliations

Aarhus University Hospital Aarhus University University of Southern Denmark The Wistar Institute Mologen (Germany)

About

Line K. Vibholm is an author at Aarhus University Hospital specializing in hiv, medicine, and viral immunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	28
2	Immunology	2	2	28
3	Cell Biology	1	1	11
4	Pharmacology	1	1	17
5	Autoimmune Disease	1	1	11

Line K. Vibholm

Publications

847

Citations

H-Index

Page 1

	Year	Citations
SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses Line K. Vibholm, Stine Sofie Frank Nielsen, Marie H. Pahus, EBioMedicine	2021	166
Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection Line K. Vibholm, Mariane Høgsbjerg Schleimann, Jesper Falkesgaard Højen, Clinical Infectious Diseases	2017	143
Effects of 24-week Toll-like receptor 9 agonist treatment in HIV type 1+ individuals Line K. Vibholm, Christina Valbirk Konrad, Mariane Høgsbjerg Schleimann, AIDS	2019	88
SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity Stine Sofie Frank Nielsen, Line K. Vibholm, Ida Monrad, EBioMedicine	2021	84
Impact of a TLR9 agonist and broadly neutralizing antibodies on HIV-1 persistence: the randomized phase 2a TITAN trial Jesper Damsgaard Gunst, Jesper Falkesgaard Højen, Marie H. Pahus, Nature Medicine	2023	68
Characterization of Intact Proviruses in Blood and Lymph Node from HIV-Infected Individuals Undergoing Analytical Treatment Interruption Line K. Vibholm, Julio C. C. Lorenzi, Joy A. Pai, Journal of Virology	2019	63
High-dose coenzyme Q10 therapy versus placebo in patients with post COVID-19 condition: a randomized, phase 2, crossover trial Kristoffer Skaalum Hansen, Trine H. Mogensen, Jane Agergaard, The Lancet Regional Health - Europe	2022	51
The TLR9 agonist MGN1703 triggers a potent type I interferon response in the sigmoid colon Astrid R Krarup, Mohamed Abdel‐Mohsen, Mariane Høgsbjerg Schleimann, Mucosal Immunology	2017	38
TLR9 agonist MGN1703 enhances B cell differentiation and function in lymph nodes Mariane Høgsbjerg Schleimann, Maria-Louise Kobberø, Line K. Vibholm, EBioMedicine	2019	35
Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Immunocompromised Host Displaying Treatment Induced Viral Evolution Ida Monrad, Signe Risgaard Sahlertz, Stine Sofie Frank Nielsen, Open Forum Infectious Diseases	2021	28

Page 1